Shorla Oncology attending CPhI North America, Philadelphia, USA

Shorla are very excited to be visiting Philadelphia week commencing 23^rd April 2018, to attend CPHI North America, an excellent platform for meeting and establishing new contacts in the Pharma World.

If you would like to arrange a meeting please contact us.

Shorla Oncology Announces FDA Filing Acceptance of New Drug Application to Treat Certain Forms of Leukemia and Other Cancers

We are delighted to be attending the HOPA 2024 conference at Tampa Florida from 3-6 April. We are looking forward to meeting you at Booth #620.

Shorla Oncology Achieves Great Place to Work Certification

FDA Receives New Drug Application for SH-105 in Breast and Ovarian Cancer

OncLive/ SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer

Targeted Oncology/ FDA Ok’s NDA for SH-105 in Breast and Ovarian Cancer

Pharmaceutical Executive/ FDA Accepts New Drug Application for Shorla Oncology’s Novel Treatment for Breast, Ovarian Cancer

Shorla Oncology Announces FDA Filing Acceptance of New Drug Application for novel formulation to treat breast and ovarian cancer

Shorla Oncology attending JP Morgan Healthcare Conference

LATEST NEWS